Surgical treatment for locally advanced lung cancer in a human immunodeficiency virus-infected patient.

Sumiko Maeda, Yoshinori Okada, Akira Sakurada, Tetsu Sado, Hisashi Oishi, Yugo Ashino, Takashi Kondo

Research output: Contribution to journalArticle

Abstract

Highly active antiretroviral therapy (HAART) has changed the most common cause of death among patients infected with the human immunodeficiency virus (HIV). These patients are known to be at increased risk for lung cancer compared with the general population. Recently, HIV-infected patients who need surgical treatment of lung cancers are becoming increasingly common. We present a 60-year-old HIV-infected man with locally advanced lung cancer with a helper T-lymphocyte count of 195 cells/μl at the time of lung cancer diagnosis. HAART was initiated before surgery, and extended resection was performed without discontinuance of HAART. The patient successfully recovered from surgery without complication.

Original languageEnglish
Pages (from-to)822-825
Number of pages4
JournalGeneral thoracic and cardiovascular surgery
Volume59
Issue number12
DOIs
Publication statusPublished - 2011 Dec

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Surgical treatment for locally advanced lung cancer in a human immunodeficiency virus-infected patient.'. Together they form a unique fingerprint.

  • Cite this